FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to therapy, and concerns the patients with obesity and arterial hypertension correction. That is ensured by adding a biologically active additive containing the following ingredients: Trekrezan, vitamins A, D2, E, B1, B2, B6, B12, PP, H, C, and microelements - calcium, magnesium, iron, selenium, zinc, fluorine, iodine, in combination with a therapeutically effective amount of Enalapril, in a daily dose of the biologically active additive 200–400 mg.
EFFECT: method provides effective reduction of arterial pressure and normalization of lipid metabolism with no side effects in this group of patients.
1 cl, 1 ex, 1 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
TRECRESAN APPLICATION FOR TREATING PATIENTS SUFFERING ARTERIAL HYPERTENSION AND OBESITY | 2010 |
|
RU2429832C1 |
METHOD OF CONDITION CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY CORRECTION | 2019 |
|
RU2740374C2 |
METHOD FOR PREDICTING ENALAPRYL EFFICIENCY IN TREATING HYPERTENSION DISEASE PATIENTS IN RUSSIAN PEOPLE POPULATION | 2006 |
|
RU2305837C1 |
METHOD OF PREVENTING RECURRENT CARDIAC INFARCTION | 2001 |
|
RU2180843C1 |
METHOD FOR TREATMENT OF SYSTEMIC AND PULMONARY ARTERIAL HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE BRONCHITIS AND BRONCHIAL ASTHMA | 2004 |
|
RU2292889C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING ARTERIAL HYPERTENSION | 2010 |
|
RU2448701C2 |
METHOD DETERMINING TACTICS OF CARRYING OUT OF MEDICAL ACTIONS AT PATIENTS WITH METABOLIC SYNDROME AGAINST ARTERIAL HYPERTENSIA | 2007 |
|
RU2337612C1 |
METHOD FOR CORRECTING COGNITIVE DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION ACCOMPANYING TYPE 2 DIABETES MELLITUS | 2014 |
|
RU2555334C1 |
METHOD OF INCREASING EFFICIENCY OF SHORT-TERM AND MIDDLE-TERM ANTIHYPERTENSIVE THERAPY AND REDUCTION OF LEFT VENTRUCLE HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-ND PHASE OF 2-ND DEGREE OF RISK 3 | 2011 |
|
RU2463043C1 |
METHOD FOR TREATING ARTERIAL HYPERTENSION | 2006 |
|
RU2310457C1 |
Authors
Dates
2020-08-06—Published
2019-02-28—Filed